Dupixent® (dupilumab) Approved in China as the First-ever …
WEB19 hours ago · TARRYTOWN, N.Y. and PARIS, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the National Medical Products Administration (NMPA) in China has approved Dupixent ® (dupilumab) as an add-on maintenance treatment for adults with ...
Press Release: Dupixent approved in China as the first-ever …
WEB19 hours ago · Dupixent approved in China as the first-ever biologic medicine for patients with COPD. Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function, and also improved health-related quality of life
33 Medical Wins 2024 Best Technology in Spine Award for …
WEB19 hours ago · Boca Raton, FL, Sept. 27, 2024 (GLOBE NEWSWIRE) -- 33 Medical, Inc., a leader in cutting-edge spinal health innovations, is proud to announce that its NuvoDisc ® medical device has been awarded the prestigious 2024 Best Technology in Spine Award.This accolade recognizes the NuvoDisc ® as a revolutionary advancement in the treatment of degenerative disc disease (DDD), offering hope and relief ...
Lexicon to Present Phase 3 Trial Design for Sotagliflozin in ...
WEB19 hours ago · Patient randomization is underway in SONATA-HCM clinical trial evaluating Lexicon’s novel dual SGLT1 and SGLT2 inhibitor in this underserved and growing patient population Study design intended to enable supplemental new drug application (sNDA) with a broad label in both obstructive and non ...
Actualité des professionnels de santé | Santé log
WEB39€ TTC. / 7 Numéros. Format numérique. Format PDF ( revue imprimable ) Découvrez la revue. Santé log site dédié à l'actualité des professionnels de santé. Santé log apporte une information pertinente et de qualité sur l'actualité médicale.
Beyond Air Announces $20.6 Million Private Placement Offering …
WEB19 hours ago · – Financing strengthens balance sheet and is expected to provide sufficient cash runway through June 2026 – – Retiring $17.5 million in Avenue Capital debt, aided by $11.5 million in new debt from insider-led group; eliminates $12 million in scheduled debt payments through June 2026 – – Avenue Capital, current insiders, and select group of healthcare-focused investment funds ...
WeightWatchers Announces Executive Leadership Transition
WEB19 hours ago · Independent Board Member Tara Comonte Will Serve as Interim Chief Executive Officer Sima Sistani Will Step Down as CEO and Director. NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today that WeightWatchers Board member Tara Comonte has been appointed Interim Chief Executive Officer.
AIM ImmunoTech to Participate in Virtual Investor CEO Connect …
WEB19 hours ago · Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET. OCALA, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, Chief Executive Officer of AIM will participate in a Virtual Investor CEO Connect segment on Wednesday, October 2 ...
COVID LONG : Une maladie impossible à diagnostiquer - santé log
WEBAug 16, 2024 · cette même inflammation persistante constitue l’un des mécanismes sous-jacents de l' anosmie et de la dysgueusie. Ainsi, la pandémie de COVID laisse un grand défi, concluent les chercheurs, celui de la compréhension, du diagnostic et du traitement du COVID long. Pourtant, à ce jour, ces formes longues ont atteint des millions de personnes.
Le vaccin, déclencheur de troubles neurologiques fonctionnels
WEBJun 20, 2022 · Les auteurs expliquent que le vaccin COVID-19 peut précipiter le développement d'un trouble neurologique fonctionnel (FND : functional neurological disorder), un trouble neuropsychiatrique caractérisé par des symptômes tels qu’une faiblesse dans les membres, des troubles de la marche, des mouvements saccadés, des tremblements et des ...
Skip to content